Home | Therapy |

People with MS, as with other chronic illnesses, may be taking a number of drugs to treat both their symptoms and the underlying disease. Some of these treatments have been widely available for years, while others have only recently been introduced.

Many drugs are provided as part of a controlled clinical trial before becoming generally available. The data from such trials are used by regulatory bodies to determine which drug should be approved for widespread use. The trial design and data are also used by doctors to choose between two similar agents.

This article is designed to give you more insight into the drug development and evaluation processes.

To customise this article to your interests, please click on the statement below that most closely reflects your reasons for reading this article:

I am interested in learning about the process of drug development	I am interested in learning about the different phases of clinical trials
I would like to understand why it takes so long for a drug to become available	I would like to know which parameters may differ from one MS clinical trial to another
I would like to find out about the particular challenges of clinical trials for MS
All of the above	None of the above

The information on this page was last updated/verified on:

March 8, 2001

Home | Links | Registration and Feedback | Search Engine and Site map | Glossary | Local Information | About this site/Help | Tell a friend | Disclaimer | Press Information | Schering